Literature DB >> 4570039

The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.

E R Block, J E Bennett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4570039     DOI： 10.3181/00379727-142-37049

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  14 in total

1.  In vitro studies with combinations of 5-fluorocytosine and amphotericin B.

Authors:  S Shadomy; G Wagner; E Espinel-Ingroff; B A Davis
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

Review 2.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

3.  Combination antifungal therapy for cryptococcal meningitis.

Authors:  J S Tobias; P F Wrigley; E Shaw
Journal:  Postgrad Med J       Date:  1976-05       Impact factor: 2.401

4.  In vitro and in vivo activity of 5-fluorocytosine on Acanthamoeba.

Authors:  A R Stevens; W D O'Dell
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

8.  Cryptococcosis after renal transplantation: report of ten cases.

Authors:  G P Schröter; D R Temple; B S Husberg; R Weil; T E Starzl
Journal:  Surgery       Date:  1976-03       Impact factor: 3.982

Review 9.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Therapy of fungal infections of the central nervous system.

Authors:  D C Speller
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.